Dow Today: Travelers Companies (TRV) Leads The Day Higher, Johnson & Johnson (JNJ) Lags

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) closed down 114.0 points (-0.7%) at 15,337. During the day, 431.9 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 564 million. The NYSE advances/declines ratio closed at 971 issues advancing vs. 2,041 declining with 106 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component that led the way higher today was Travelers Companies (NYSE: TRV), which sported a 24-cent gain (+0.3%) bringing the stock to $82.18. Volume for Travelers Companies ended the day at 1.9 million shares traded vs. an average daily trading volume of 2.2 million shares.

Travelers Companies has a market cap of $30.74 billion and is part of the financial sector and insurance industry. Shares are up 14.6% year to date as of Tuesday's close. The stock's dividend yield sits at 2.4%.

The Travelers Companies, Inc., through its subsidiaries, provides various commercial and personal property and casualty insurance products and services to businesses, government units, associations, and individuals primarily in the United States.

TheStreet Ratings rates Travelers Companies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, compelling growth in net income, notable return on equity and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins.

Holding the Dow back today was Johnson & Johnson (NYSE: JNJ), which lagged the broader Dow index with a $2.31 decline (-2.5%) bringing the stock to $90.70. This single loss is lowering the Dow Jones Industrial Average by 17.48 points or roughly accounting for 15.3% of the Dow's overall loss. Volume for Johnson & Johnson ended the day at 12.5 million shares traded vs. an average daily trading volume of 9.9 million shares.

Johnson & Johnson has a market cap of $259.26 billion and is part of the health care sector and drugs industry. Shares are up 31.2% year to date as of Tuesday's close. The stock's dividend yield sits at 2.9%.

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.

TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Allstate and Travelers Likely Spared From Worst Hurricane Irma, Harvey Damages

Travelers Halts Share Buybacks as Hurricane Harvey Losses Mount

How to Make Easy Money on Apple's iPhone X Worldwide Reveal: Market Recon

Travelers Halts Buybacks as it Reviews Losses From Hurricanes Harvey and Irma